Vimarsana
Biggest News Aggregation in the World

David Spaight News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Spaight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Spaight Today - Breaking & Trending Today

Certara Announces the Completion of Arsenal Capital Partners' Investment and the Appointment of David Spaight to the Board of Directors - Vimarsana News

Certara Announces the Completion of Arsenal Capital Partners' Investment and the Appointment of David Spaight to the Board of Directors

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”)...

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta - Vimarsana News

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta MONTREAL, Jan. 26, 2021 /PRNewswire/ – Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry, is pleased to announce its new corporate name, CellCarta, and brand identity. The new name for the Montreal-headquartered company stems from the 2019 combination of contract research organization Caprion Biosciences, which specializes in immunology and proteomics services, and HistoGeneX, a provider of histopathology and genomics services based in Ant...

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta » Notizie italiane in tempo reale! - Vimarsana News

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta » Notizie italiane in tempo reale!

26 gennaio 2021 MONTREAL, Jan. 26, 2021 /PRNewswire/ — Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry, is pleased to announce its new corporate name, CellCarta, and brand identity. The new name for the Montreal-headquartered company stems from the 2019 combination of contract research organization Caprion Biosciences, which specializes in immunology and proteomics services, and HistoGeneX, a provider of histopathology and genomics services based in Antwerp. Recently, CellCarta further expanded its scien...

Source: ecomy.it
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories - Vimarsana News

Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories

Press release content from PR Newswire. The AP news staff was not involved in its creation. Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories January 12, 2021 GMT MONTREAL, Jan. 12, 2021 /PRNewswire/ - Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners (“Arsenal”), announced today the acquisition of Mosaic Laboratories LLC (“Mosaic”), a California-based company offering histology and immunohistochemistry services to global pharmaceutical clients. The addition of...

Source: apnews.com